mRNA Advancements Targeting Cancer: Tsinghua University Investigational Review of the Landscape

mRNA vaccines were accelerated during the COVID-19 pandemic, showcasing not only the potential against viruses but also to target cancer, given the growing pipeline of mRNA-based cancer drugs. 

Recently, Ling Ni, Ph.D. at the Institute for Immunology, School of Medicine, Tsinghua University, authored a paper featuring not only general advances in mRNA therapeutic and vaccine development targeting cancer but also a breakdown of the building clinical trials pipeline.